February 10, 2020The American Bar Foundation Establishes the William C. Hubbard Law and Education Conference Endowment
October 16, 2019
NEW YORK – Nelson Mullins Riley & Scarborough LLP announced today that Maya Elbert, Ph.D., has joined the Intellectual Property team as of counsel and will be based in New York. She joins from Jones Day, where she was an associate.
Dr. Elbert has extensive experience in a wide variety of intellectual property matters, with a focus on patent procurement, strategic counseling, and transactional work in the areas of biotechnology and pharmaceuticals. Her practice includes working with life sciences companies to build patent portfolios, preparation and prosecution of domestic and international patent applications, patent portfolio management, patentability evaluations and assessing the strength of intellectual property assets, preparation of validity and noninfringement opinions, freedom-to-operate analyses and due diligence evaluations of patent portfolios. Dr. Elbert has experience with a wide range of technologies, including small molecules, antibodies, CRISPR technology, proteins and peptides, CAR T cells and other cellular therapeutics, nutritional supplements, gene therapy, biopolymers, hematopoietic stem cells, nucleic acid technology, and pharmaceutical formulations.
She earned her Ph.D. in pharmacology in 2004 from Cornell University Weill Graduate School of Medical Sciences, a J.D. from Georgetown University Law Center in 2007, and a B.S. in biology from St. Petersburg State University (Russia).
These materials have been prepared for informational purposes only and are not legal advice. This information is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Internet subscribers and online readers should not act upon this information without seeking professional counsel.